US 12,344,583 B2
Solid psilocin salts
Frederick Sancilio, Stuart, FL (US); Yousry Sayed, Wilmington, NC (US); Maghsoud Dariani, Fanwood, NJ (US); Scott Mough, Wilmington, NC (US); Shaileshkumar Ramanlal Desai, Wilmington, NC (US); and Autumn Beauchamp, Wilmington, NC (US)
Assigned to Lobe Sciences Ltd., Vancouver (CA)
Filed by LOBE SCIENCES LTD., Vancouver (CA)
Filed on Sep. 18, 2024, as Appl. No. 18/888,371.
Application 18/888,371 is a continuation in part of application No. PCT/US2023/027500, filed on Jul. 12, 2023.
Claims priority of provisional application 63/573,567, filed on Apr. 3, 2024.
Claims priority of provisional application 63/388,414, filed on Jul. 12, 2022.
Prior Publication US 2025/0019348 A1, Jan. 16, 2025
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 209/16 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 31/4045 (2006.01); A61K 31/675 (2006.01)
CPC C07D 209/16 (2013.01) [A61K 9/0053 (2013.01); A61K 9/4825 (2013.01); A61K 31/4045 (2013.01); A61K 31/675 (2013.01)] 12 Claims
 
1. A solid form of psilocin mucate, at least a portion of which is crystalline and is characterized by an X-ray powder diffraction (XRPD) pattern comprising peaks at about 14.71, 15.75, 19.57 and 23.20 2θ, ° using Cu Kα radiation.